BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
FRA:BRYN - Deutsche Boerse Ag - US0846707026 - Common Stock - Currency: EUR
Overall BRYN gets a fundamental rating of 5 out of 10. We evaluated BRYN against 49 industry peers in the Financial Services industry. BRYN has an average financial health and profitability rating. BRYN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
BRYN had positive earnings in the past year.
In the past year BRYN had a positive cash flow from operations.
BRYN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BRYN had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 6.95%, BRYN is doing good in the industry, outperforming 77.55% of the companies in the same industry.
BRYN's Return On Equity of 12.36% is fine compared to the rest of the industry. BRYN outperforms 63.27% of its industry peers.
The Return On Invested Capital of BRYN (4.50%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BRYN is below the industry average of 9.06%.
The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.50%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.95% | ||
| ROE | 12.36% | ||
| ROIC | 4.5% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
Looking at the Profit Margin, with a value of 21.79%, BRYN is in the better half of the industry, outperforming 77.55% of the companies in the same industry.
BRYN's Profit Margin has declined in the last couple of years.
The Operating Margin of BRYN (15.89%) is better than 65.31% of its industry peers.
BRYN's Operating Margin has improved in the last couple of years.
BRYN has a Gross Margin (16.43%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BRYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 21.79% | ||
| GM | 16.43% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRYN is still creating some value.
Compared to 1 year ago, BRYN has less shares outstanding
The number of shares outstanding for BRYN has been reduced compared to 5 years ago.
The debt/assets ratio for BRYN has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.34, we must say that BRYN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BRYN (1.34) is comparable to the rest of the industry.
BRYN has a debt to FCF ratio of 10.44. This is a negative value and a sign of low solvency as BRYN would need 10.44 years to pay back of all of its debts.
BRYN has a Debt to FCF ratio of 10.44. This is comparable to the rest of the industry: BRYN outperforms 51.02% of its industry peers.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
BRYN has a better Debt to Equity ratio (0.19) than 67.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 10.44 | ||
| Altman-Z | 1.34 |
ROIC/WACC1.39
WACC3.23%
2.3 Liquidity
BRYN has a Current Ratio of 1.14. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BRYN (1.14) is comparable to the rest of the industry.
BRYN has a Quick Ratio of 1.14. This is a bad value and indicates that BRYN is not financially healthy enough and could expect problems in meeting its short term obligations.
BRYN has a Quick ratio of 0.91. This is in the lower half of the industry: BRYN underperforms 61.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.77%, which is quite good.
BRYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.78% yearly.
The Revenue has been growing slightly by 0.63% in the past year.
BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
3.2 Future
Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 2.27% on average per year.
Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 6.94% on average per year.
EPS Next Y-5.7%
EPS Next 2Y-0.22%
EPS Next 3Y1.32%
EPS Next 5Y2.27%
Revenue Next Year4.56%
Revenue Next 2Y4.16%
Revenue Next 3Y0.25%
Revenue Next 5Y6.94%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 0.02 indicates a rather cheap valuation of BRYN.
Based on the Price/Earnings ratio, BRYN is valued cheaply inside the industry as 97.96% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BRYN to the average of the S&P500 Index (26.17), we can say BRYN is valued rather cheaply.
The Price/Forward Earnings ratio is 0.02, which indicates a rather cheap valuation of BRYN.
BRYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 97.96% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. BRYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaply inside the industry as 95.92% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRYN indicates a rather cheap valuation: BRYN is cheaper than 97.96% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.06 | ||
| EV/EBITDA | 1.15 |
4.3 Compensation for Growth
The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y-0.22%
EPS Next 3Y1.32%
5. Dividend
5.1 Amount
No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (5/29/2025, 5:29:46 PM)
442.875
-4.27 (-0.96%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners33.43%
Inst Owner ChangeN/A
Ins Owners37.69%
Ins Owner ChangeN/A
Market Cap637.74M
Analysts80
Price Target477.35 (7.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-9.78%
Max EPS beat(2)42.8%
EPS beat(4)2
Avg EPS beat(4)10.96%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)11.15%
EPS beat(12)8
Avg EPS beat(12)9.18%
EPS beat(16)11
Avg EPS beat(16)8.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.05%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-0.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)5
Avg Revenue beat(12)-0.61%
Revenue beat(16)6
Avg Revenue beat(16)-0.89%
PT rev (1m)-1.96%
PT rev (3m)-2.58%
EPS NQ rev (1m)-1.97%
EPS NQ rev (3m)5.69%
EPS NY rev (1m)-2.25%
EPS NY rev (3m)1.05%
Revenue NQ rev (1m)4.96%
Revenue NQ rev (3m)4.13%
Revenue NY rev (1m)4.55%
Revenue NY rev (3m)3.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.02 | ||
| P/S | 0 | ||
| P/FCF | 0.06 | ||
| P/OCF | 0.02 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 1.15 |
EPS(TTM)28188.26
EY6364.83%
EPS(NY)29027.99
Fwd EY6554.44%
FCF(TTM)7403.44
FCFY1671.68%
OCF(TTM)18978.9
OCFY4285.39%
SpS227833.86
BVpS401602.68
TBVpS328306
PEG (NY)N/A
PEG (5Y)0
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.95% | ||
| ROE | 12.36% | ||
| ROCE | 5.56% | ||
| ROIC | 4.5% | ||
| ROICexc | 4.68% | ||
| ROICexgc | 5.61% | ||
| OM | 15.89% | ||
| PM (TTM) | 21.79% | ||
| GM | 16.43% | ||
| FCFM | 3.25% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexcg growth 3Y9.15%
ROICexcg growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 10.44 | ||
| Debt/EBITDA | 1.75 | ||
| Cap/Depr | 145.65% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 11.99 | ||
| Cash Conversion | 42.99% | ||
| Profit Quality | 14.91% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 1.34 |
F-Score4
WACC3.23%
ROIC/WACC1.39
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-14.02%
EPS Next Y-5.7%
EPS Next 2Y-0.22%
EPS Next 3Y1.32%
EPS Next 5Y2.27%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-0.16%
Revenue Next Year4.56%
Revenue Next 2Y4.16%
Revenue Next 3Y0.25%
Revenue Next 5Y6.94%
EBIT growth 1Y12.44%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-47.83%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-21.13%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%